Date: 2024-09-27 Page is: DBtxt003.php txt00010819 | |||||||||
Health ... Malaria | |||||||||
Burgess COMMENTARY | |||||||||
PATH malaria work on the agenda at ASTMH Join us at the American Society of Tropical Medicine and Hygiene (ASTMH) annual meeting this week in Philadelphia, where PATH experts will be sharing exciting new research from our Malaria Center of Excellence—PATH’s robust portfolio of malaria projects ranging from diagnostics, vaccines, drug development, and groundbreaking new strategies. Presentations will highlight the research and development of new tools and products to diagnose and treat malaria, the optimization of existing tools and strategies to further drive down transmission, and targeted strategies to stop the disease’s spread. The following PATH projects will be presenting research: The Malaria Control and Elimination Partnership in Africa (MACEPA) is investigating new ways to use diagnostics and treatment to clear parasites from populations, and will share results from studies assessing the efficacy and feasibility of implementing mass treatment with artemisnin-based combination therapies to reduce malaria transmission to near-zero levels, as well as studies evaluating the costs of implementing tools and surveillance systems to support malaria elimination. PATH’s Diagnostics team will present research on G6PD testing to ensure safe treatment of Plasmodium vivax malaria. The development of an effective G6PD test will also be critical to informing decision-making around the development of a radical cure—a single-dose treatment for malaria. The team will also share new information on the development of more sensitive point-of-care diagnostic for P. falciparum malaria, which will more effectively diagnose malaria infections among people with low density and asymptomatic infections. Malaria Vaccine Initiative (MVI) researchers will participate in a symposium addressing how to assess vaccines for elimination and eradication, as well as presentations on modeling data and genomic methods that help explain the protective effects of RTS,S—the world’s most advanced malaria vaccine candidate. MalariaCare staff will share research on strengthening high-quality diagnosis and treatment services for malaria, including improving fever case management through providing support to medicine vendors. Those unable to make it to Philly can still pose questions to the many malaria experts in attendance at ASTMH by participating in the conference’s Fireside Malaria Chat on Tuesday, October 27, from noon to 2 p.m. To participate, use the hashtag #TropMedChat. Here is a full list of PATH malaria presentations at ASTMH: Monday, October 26 Poster session A (noon–1:45 p.m., Convention Center, Ballroom AB):
Tuesday, October 27 Poster session B (noon–1:45 p.m., Convention Center, Ballroom AB):
Wednesday, October 28 Oral presentation: Infrastructure and interpretation of mosquitoes fed directly on human vaccines (11:15 a.m.–noon, Marriott Grand Ballroom Salon E). Part of the Assays to measure malaria transmission: How will we assess vaccines for elimination and eradication? symposium, 10:15 a.m.–noon. Poster session C (noon–1:45 p.m., Convention Center, Ballroom AB):
Thursday, October 29 Oral presentations: Malaria elimination program questions needing genetic approaches (10:15–10:30 a.m., Marriott Grand Ballroom Salon G). Part of the Molecular epidemiology for malaria control and elimination: Ready for prime time or a last mile tool? symposium, 10:15 a.m.–noon. Clustering of imported malaria cases in a setting of very-low malaria incidence in northern Senegal (10:45–11: 00 a.m., Marriott Grand Ballroom Salon F). Part of the Malaria: Public Health Challenges and Control Strategies scientific session, 10:15 a.m.–noon. Symposiums organized: New tools for detection of individuals with low levels of malaria infection (10:15–noon, Marriott Grand Ballroom Salon E). |